Can Dimon, JPMorgan’s Stock Survive Senate Scarlet Letter?

Getty Images

CNBC.com – By John Melloy – June 13, 2012

Investors fear that Jamie Dimon and JPMorgan may suffer the same fate as Lloyd Blankfeinand Goldman Sachs following the former CEO’s testimony before the Senate: a soiled reputation and an underperforming stock.

In April 2010, following a marathon grilling in front of the Senate’s Permanent Subcommittee on Investigations, shares of Blankfein’s Goldman Sachs have underperformed the market and the rest of the financial industry.

Part of the reason is the curtailment of trading activities by the bank to avoid further scrutiny (and another trip before Congress) and loss of banking business because of the reputational hit that the hearing caused.

To read the full article please click here.

Advertisements
This entry was posted in Articles, Business, Finance, U.S. Economy, World Economy, World Exchanges and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s